PROGENIKA BIOPHARMA, S.A. based in Derio, ES has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-04-17

US20250122557A1

Chemistry; metallurgy

MITOCHONDRIAL NUCLEIC ACID DEPLETION AND DETECTION

#2 | 2021-08-19 ✅ Patent 12,215,376 granted on 2025-02-04

US20210254135A1

Chemistry; metallurgy

Mitochondrial nucleic acid depletion and detection

#3 | 2021-01-14 ✅ Patent 12,422,444 granted on 2025-09-23

US20210011037A1

Physics

LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES AGAINST BIOLOGICAL DRUGS

#4 | 2018-10-25 ✅ Patent 10,851,413 granted on 2020-12-01

US20180305756A1

Chemistry; metallurgy

Consensus-based allele detection

#5 | 2017-08-17 ✅ Patent 10,830,779 granted on 2020-11-10

US20170234896A1

Physics

Lateral flow immunoassays for the detection of antibodies against biological drugs

#6 | 2016-08-25 ✅ Patent 10,253,366 granted on 2019-04-09

US20160244830A1

Chemistry; metallurgy

Discrimination of blood type variants

#7 | 2016-03-03

US20160060696A1

Chemistry; metallurgy

METHOD FOR THE IDENTIFICATION BY MOLECULAR TECHNIQUES OF GENETIC VARIANTS THAT ENCODE NO D ANTIGEN (D-) AND ALTERED C ANTIGEN (C+W)

#8 | 2016-02-04

US20160032386A1

Chemistry; metallurgy

GENETIC MARKERS FOR OSTEOARTHRITIS

#9 | 2016-01-14

US20160010160A1

Chemistry; metallurgy

PROGNOSTIC METHOD

#10 | 2014-09-11 ✅ Patent 9,359,643 granted on 2016-06-07

US20140255923A1

Chemistry; metallurgy

Discrimination of blood type variants

#11 | 2014-08-07 ✅ Patent 9,637,788 granted on 2017-05-02

US20140220567A1

Chemistry; metallurgy

Discrimination of blood type variants

#12 | 2013-10-03

US20130263294A1

Chemistry; metallurgy

MARKERS FOR JOINT DISPLASIA, OSTEOARTHRITIS AND CONDITIONS SECONDARY THERETO

#13 | 2011-12-22 ✅ Patent 9,165,108 granted on 2015-10-20

US20110313678A1

Chemistry; metallurgy

Probes and methods for determining the presence or absence of genetic segments

#14 | 2011-04-28

US20110098191A1

Physics

IN VITRO METHODS FOR DETECTING RENAL CANCER

#15 | 2010-07-22 ✅ Patent 9,109,257 granted on 2015-08-18

US20100185429A1

Chemistry; metallurgy

Prognostic method

#16 | 2010-04-08 ✅ Patent 8,712,696 granted on 2014-04-29

US20100087441A1

Chemistry; metallurgy

Methods of prognosing a rheumatoid arthritis remission phenotype

#17 | 2010-03-18 ✅ Patent 8,153,363 granted on 2012-04-10

US20100068710A1

Physics

Methods and products for in vitro genotyping

#18 | 2008-11-06

US20080274968A1

Physics

IN VITRO METHODS FOR DETECTING RENAL CANCER

#19 | 2008-03-20 ✅ Patent 7,914,990 granted on 2011-03-29

US20080070253A1

Chemistry; metallurgy

Methods and products for in vitro genotyping

#20 | 2007-04-26 ✅ Patent 8,124,331 granted on 2012-02-28

US20070092878A1

Physics

In vitro method to detect bladder transitional cell carcinoma

Also check out Progenika Biopharma S.A.'s (Derio, Spain) applicant profile with 7 patent applications submitted.

AssigneeID:

41609 ⎘